A milestone for the deadliest form of cancer: a vaccine for patients who have undergone pancreatic cancer surgery appears to dramatically lower the risk of the disease returning. Erasmus MC in Rotterdam will participate in follow-up research, but warns against too high expectations.
ttn-43